
Photo: LVM3 launch, Sriharikota, ISRO, GODL-India
APPSC Group-I Mains 2020 · Paper V
2020 Paper V · Q7(a): model answer
Science, Technology & Environmental Issues · Biotechnology and health. Held in December 2020 (Notification 27/2018).
Is there any difference between gene therapy, transgenic organisms, and gene enhancement/genome editing? With example, explain the ethical concerns in each of these approaches? When can genome editing be considered ethical?
Syllabus: Biotechnology and health · Biotechnology
Gene therapyTransgenic organismsGenome editingBioethics
Yes, the three differ in aim and method, though all alter genetic material. Gene therapy treats a patient's disease by adding, silencing or correcting genes in his or her cells. A transgenic organism carries a gene from another species, introduced by recombinant DNA technology. Genome editing (such as CRISPR-Cas9, 2012) makes precise changes in an organism's own DNA; used beyond treating disease, to improve normal traits, it becomes gene enhancement.
| Feature | Gene therapy | Transgenic organism | Genome editing and enhancement |
|---|---|---|---|
| What changes | A working gene added, or a faulty one silenced, in a patient's cells | A foreign gene inserted into a plant, animal or microbe | The organism's own DNA cut and changed at a chosen spot |
| Main tools | Viral vectors (lentivirus, AAV); modified immune cells | Restriction enzymes, plasmids, Agrobacterium, gene gun | CRISPR-Cas9 or Cas12a, base editors |
| Examples | Haemophilia A trial, CMC Vellore (2024); NexCAR19 CAR-T (2023) | Bt cotton (2002); GM mustard DMH-11 | Genome-edited rice (2025); Casgevy for sickle cell (2023) |
| Main ethical worry | Safety, cost, consent | Biosafety, gene flow, seed monopoly | Off-target edits; germline "designer babies" |
1. Ethical concerns in gene therapy
- Safety: viral vectors can trigger severe immune reactions or insert into the wrong place and cause cancer; a US trial volunteer, Jesse Gelsinger, died in 1999.
- Cost and equity: some therapies cost crores of rupees per patient; India's NexCAR19 shows cheaper local options are possible.
- Consent: patients are often children or desperate adults, so informed, voluntary consent needs special care.
2. Ethical concerns with transgenic organisms
- Biosafety: gene flow to wild relatives, harm to non-target insects and resistant pests (pink bollworm now resists Bt cotton).
- Farmers and markets: seed monopolies, debt and the right to save seed; consumer choice and labelling of GM food.
- Animal welfare: transgenic animals used as "bioreactors" or disease models suffer.
- Governance: in India the GEAC must approve release; Bt brinjal has been under a moratorium since 2010, and GM mustard awaits a Supreme Court ruling.
3. Ethical concerns with genome editing and enhancement
- Germline editing: changes in embryos pass to future generations, who cannot consent. In 2018 a Chinese scientist, He Jiankui, edited twin embryos and was jailed in 2019.
- Enhancement and inequality: editing for height, intelligence or looks revives eugenics and could create a genetic divide between rich and poor.
- Unknown risks: off-target cuts and mosaicism; gene drives could alter wild populations irreversibly; dual-use (bioweapon) fears.
4. When can genome editing be considered ethical?
- In medicine, editing a patient's own cells to treat a grave disease (as Casgevy and India's BIRSA 101 do for sickle cell disease) meets these tests; India's ICMR guidelines (2019) prohibit germline gene therapy.
- In crops, edits without foreign DNA (SDN-1 and SDN-2) are exempt from GM rules since March 2022, but still need biosafety checks and transparency.
AP angle: India's first genome-edited rice varieties (May 2025) were developed from Samba Mahsuri, bred at Bapatla, and MTU 1010, bred at Maruteru.
Genetic technologies are tools, not ends. Guided by bioethics, strong regulation and public dialogue, genome editing can relieve suffering without crossing into designer babies.
The other choice in Q7
Answer either one in the exam.
Every model answer on these pages is free to read. The Tool Kit adds four PDF books for Mains Papers I–IV: every previous question sorted by syllabus, with practice questions. It is in the ₹149 All-in-One Pass, with every previous paper of every exam on the site, practice quizzes, timed tests, mock test series and study books.
₹149 · valid for 12 months from the day you pay, on every exam · pay by UPI, card or net banking